Dichiarazione di accessibilità Salta la navigazione
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
  • Overview
  • Marketing
  • IR & Compliance
  • Agency
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Richiedi maggiori informazioni
    • Telefono

    • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

    • Contattaci
    • Contattaci

      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR

Conversations with Nobel Prize Winners: The Fondazione Menarini launches their 'Dialogs Beyond Borders' series
  • Latin America - español
  • USA - español
  • USA - Français
  • Brazil - Português
  • USA - Deutsch
  • USA - English
  • Italia - Italiano

Fondazione Internazionale Menarini Logo

Notizia fornita da

Menarini Industrie Farmaceutiche Riunite

02 feb, 2022, 11:07 GMT

Condividi articolo

Share toX

Condividi articolo

Share toX

FLORENCE, Italy, Feb. 2, 2022 /PRNewswire/ -- Who are the heroes that have inspired the careers of Nobel Prize winners? What difficulties have they encountered and how did they overcome them? Each and every one of us can now delve into the careers and personal lives of some of the biggest names in the world of science thanks to "Dialogs Beyond Borders," a new section on the website of the Fondazione Internazionale Menarini, with interviews given by scientists of the calibre of Louis Ignarro, Donna Strickland and Barry Marshall.

Continue Reading
Dialogs Beyond Borders, Prof. Tasuku Honjo, Nobel Prize in 2018 Physiology or Medicine
Dialogs Beyond Borders, Prof. Tasuku Honjo, Nobel Prize in 2018 Physiology or Medicine

"My father was originally from Torre del Greco and my mother from Panarea. They first met in the United States, before the Second World War: my English was very poor at first and, as you can imagine, my parents were not able to help me much with reading and writing. But fortunately I have always been very curious, even at a young age. Mine has truly been an American Success Story," commented Louis Ignarro, Nobel Prize winner in Physiology or Medicine "for his contribution to discovering the effects of the nitric oxide molecule on the cardiovascular system."

Amongst the great names hosted in the "Beyond Borders" series, you can find Donna Strickland, winner of the Nobel Prize in Physics in 2018 for "revolutionary inventions in the field of laser physics," and Tasuku Honjo, who won the Nobel Prize in Medicine in 2018 for his research on how to use the immune system as a weapon to fight cancer. His studies in the field of immunotherapy, conducted alongside his colleague James Allison, are considered a milestone in the fight against cancer.

Just a click and you can listen to the story of Barry Marshall who became Nobel Prize winner in Medicine in 2005 thanks to his discovery of the role of Helicobacter Pylori in ulcer disease.

"With this new format, we wanted to create an informal conversation with some of the great names in scientific research - many of whom are Nobel prize winners - and be able to explore some aspects of the personal lives of individuals who, through their studies and determination, have had a major impact on patients' lives and who might even inspire others to pursue a career in the Life Sciences sector," explained Lorenzo Melani, Chairman and Scientific Director of the Fondazione Internazionale Menarini.

The video interviews are available here: www.en.fondazione-menarini.it/Home/Dialogs-Beyond-Borders.

Photo - https://mma.prnewswire.com/media/1739000/Prof_Tasuku_Honjo.jpg
Logo - https://mma.prnewswire.com/media/1738999/Fondazione_Internazionale_Menarini_Logo.jpg

Modal title

Sempre da questa fonte

Le domande di autorizzazione all'immissione in commercio di obicetrapib e obicetrapib/ezetimibe del Gruppo Menarini sono state accettate per la revisione dall'Agenzia Europea per i Medicinali (EMA) nel trattamento di adulti con ipercolesterolemia primaria (familiare eterozigote e non familiare) o dislipidemia mista

Le domande di autorizzazione all'immissione in commercio di obicetrapib e obicetrapib/ezetimibe del Gruppo Menarini sono state accettate per la revisione dall'Agenzia Europea per i Medicinali (EMA) nel trattamento di adulti con ipercolesterolemia primaria (familiare eterozigote e non familiare) o dislipidemia mista

Menarini Group (Menarini), azienda farmaceutica internazionale privata con sede in Italia, oggi ha annunciato che l'EMA ha convalidato la domanda di...

PREMIO INTERNAZIONALE FAIR PLAY MENARINI, TRIONFO DI EMOZIONI PER LA 29° EDIZIONE

PREMIO INTERNAZIONALE FAIR PLAY MENARINI, TRIONFO DI EMOZIONI PER LA 29° EDIZIONE

Una notte sospesa tra storia e leggenda, ha consacrato i valori più autentici dell'etica e del fair play. Al Teatro Romano di Fiesole, dove la...

Altri comunicati stampa da questa fonte

Esplora

Intrattenimento

Intrattenimento

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

New Products & Services

New Products & Services

Comunicati stampa su argomenti simili

Contatta PR Newswire

  • +44 (0)20 7454 5110
    da 8 AM - 5 PM GMT

Siti globali

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania

 

  • India
  • Indonesia
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Middle East - Arabic
  • Olanda
  • Norvegia
  • Polonia

 

  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Unito
  • Stati Uniti

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Siti globali
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania
  • India
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Olanda
  • Norvegia
  • Polonia
  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Uniti
  • Stati Uniti
+44 (0)20 7454 5110
da 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.